Personalized Cell Therapy Market to Surpass US$ 21.4 Billion Threshold by 2024, With High Cancer Prevalence Supporting Growth - Coherent Market Insights

Published On : May 26, 2017

The Global Personalized Cell Therapy Market was valued at US$ 3536.2 million in 2016 and is projected to expand at a CAGR of 25.3% during the forecast period (2017–2024 ), as highlighted in a new report published by Coherent Market Insights. The demand for disease specific drugs for treatment of disease that have high prevalence rate, for example autoimmune diseases, diabetes and cancer is expected to support growth of the personalized cell therapy market over the forecast period.

The main process that involved the use of personalized medicine is to get the right treatment for a particular patient depending on the patient’s genomics by the help of molecular biomarker tests and targeted therapies. Autoimmune diseases are the leading cause of death, as they are prevalent in almost every age group, though their incidence rate varies with estimates as more than 80 individual type of autoimmune diseases are present such as type I diabetes, rheumatoid arthritis, inflammatory bowel disease and many more. For instance, there were around 20 cases of rheumatoid arthritis per 100,000 person in a year. Although, its prevalence rates range from less than 5 per 100 000 to more than 500 per 100 000.

The genetic and other predictive information allows the physician to prepare the treatment regime for the specific disease as per patient requirement, also it helps to pin point optimal dosing system, preventing adverse events and focus efforts on prevention and earlier interventions.

There are various approaches involved in the personalized cell therapy that can be effective in oncology, cardiac and other chronic disorders. The approach is often multi-faceted, as it helps in various components during the treatment such as risk assessment, diagnosis, prevention, detection, management and treatment.

To know the latest trends and insights prevalent in the personalized cell therapy market, click the link below:

As of 2017, around 40 cell therapy approved products are available in the market. Furthermore, leading market players such as Novartis and Kite Pharma are anticipated to launch novel products in 2017, followed by its commercialization in the following two to three years. In 2017, CAR-T cell product was launched, which is expected to drive growth of the personalized cell therapy market. Personalized cell therapy market is projected to gain traction over the forecast period, owing to development and commercialization of novel products by key players in the market. Furthermore, increasing number of drugs in pipeline for instance, CTL019 (tisagenlecleucel-T) and Kte-C19 (axicabtagene ciloleucel) are expected to boost growth of the global personalized cell therapy market over the forecast period. According to the University of Nottingham, in 2009, various collaboration were reported among market players with around 411 cell therapy deals between 1987 and 2008. Therefore, acquisitions and collaboration in cell therapy sector is expected to support growth of the global personalized cell therapy market.

Key takeaways of the personalized cell therapy market:

  • The global personalized cell therapy market is expected to expand at a CAGR of 25.3% during the forecast period (2017–2024). Paradigm shift in treatment technologies towards development of drugs is expected to favor growth of the personalized cell therapy market.
  • The platelet transfusions application segment in the global personalized cell therapy market was estimated to be the largest in 2016 and is expected to retain its dominance in the market throughout the forecast period in terms of value
  • In terms of therapeutic area segment, the cancer treatment area is estimated to be the largest segment as in this are the unmet needs are high and continuous drug development are underway in this disease area.
  • The global personalized cell therapy market is characterized by market expansion in Asia Pacific, Latin America, and Middle East could generate higher market revenue as this market is expected to lucrative market for industry players, also various studies that are being done in different countries of Latin America such as Brazil and Mexico to develop drugs based on personalized cell therapy
  • Some of the major companies in the global personalized cell therapy market are Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., M olMed S.p.A. and Vericel Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.